Back to Journals » International Journal of General Medicine » Volume 17

Clinical Significance of D-dimer Level and Numeric Rating Scale with Amount of Sinus Involvement in Cerebral Sinus Thrombosis Patients

Authors Amalia L , Ardo RT

Received 28 February 2024

Accepted for publication 20 April 2024

Published 14 May 2024 Volume 2024:17 Pages 2143—2149

DOI https://doi.org/10.2147/IJGM.S460407

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Redoy Ranjan



Lisda Amalia, Ryan Tantri Ardo

Department of Neurology, Medical Faculty, Universitas Padjadjaran/Hasan Sadikin General Hospital, Bandung, Indonesia

Correspondence: Lisda Amalia, Department of Neurology, Medical Faculty, Universitas Padjadjaran/Hasan Sadikin General Hospital, Jl. Eykman 38, Bandung, 40161, Indonesia, Email [email protected]

Introduction: Cerebral venous sinus thrombosis (CVST) is a cerebral vascular disorder that currently occurs quite often and has very varied clinical symptoms. Headache is the main symptom most commonly found in patients with CVST and multiple sinus involvement often have a more severe prognosis and poor clinical outcome. This study aimed to learn the relationship between D-dimer level, numeric rating scale (NRS), and amount of sinus involvement in CVST patients.
Methods: This study was a retrospective observational analytic study with a cross-sectional approach using medical records and supporting data (D-dimer level and imaging finding) on patients diagnosed with CVST at Dr Hasan Sadikin Hospital Bandung.
Results: Sixty-five CVST patients met the study criteria with mean age of 47 years and mostly female (76.9%). Patients with single sinus involvement had a median initial NRS of 4 (range 2– 6) and multiple sinus involvement was higher at 8 (range 5– 9). Statistical test results showed a significant difference between D-dimer level, NRS and amount of sinus involvement (P< 0.001).
Conclusion: D-dimer level, NRS, and amount of sinus involvement are associated with amount of sinus involvement in CVST patients. Involvement of multiple sinus will cause higher NRS with higher D-dimer level.

Keywords: CVST, D-dimer, NRS, sinus involvement

Introduction

Cerebral venous sinus thrombosis (CVST) is a brain blood vessel disorder that has very varied clinical symptoms refers to thrombosis in cerebral vein.1,2 CVST is a neurological disorder that is currently common and has serious consequences, and can become irreversible if it is not diagnosed quickly and does not receive appropriate treatment.1,3 Cerebral infarction, hemorrhage, and death are serious complications that could occur from misdiagnosing this condition.4 CVST affects approximately two to seven cases per one million people each year, 61% of whom are women aged between 20 and 35 years.3,5

Headache (93.7%) is the most common symptom of CVST followed by decreased consciousness (90.6%), seizures (75%), and focal neurological deficits (46.8%).6–8 Unilateral headaches ipsilateral to the involved sinus often occur in single sinus involvement caused by stretching of the dura innervated by branches of the trigeminal nerve. Multiple sinus involvement results in a predominance of increased intracranial pressure, causing widespread and extensive stretching of the dura.9 The pain-sensitive structures involved may be cerebral sinuses or veins. With this mechanism, of course, the greater the number of pain-sensitive structures involved, the higher the degree of pain that appears. From previous study, it was said that if two sinuses were involved, the area of headache felt was wider than if one sinus was involved.9

The presence of D-dimer may be used as an indicator of endogenous fibrinolysis in CVST. D-dimers are cross-linked fibrin fragments that have a high sensitivity for investigating cerebral venous thrombosis, and elevation of D-dimer is strongly associated with the number of sinus involvement because of the amount of thrombus formation circumstances that arise. High levels of D-dimer will cause presence of larger thrombi.4

The prognosis in CVST patients can be related to the number of sinuses involved, where multiple sinuses will have more severe clinical outcomes than single sinus involvement. Patil et al found that CVST patients with involvement of more than one sinus more often had sequelae and a more severe clinical outcome.10 This study will investigate the relationship between D-dimer level, numeric rating scale (NRS), and amount of sinus involvement in CVST patients.

Methods

Study Design and Population

This research is a retrospective observational analytical study with a cross-sectional approach in CVST patients aged >18 years, confirmed by magnetic resonance venography or digital subtraction angiography examination, have D-dimer data, and do not meet the exclusion criteria such as of central nervous system infection, intracranial blood vessel inflammation, blood vessel rupture, nose infection, ear infection, deep vein thrombosis, pulmonary embolism, and also dental and mouth infections.

Assessment of Pain Level

The level of pain is measured using the numeric rating scale and the level of pain is classified. The pain scale at 0 means no pain, 1–3 indicate mild pain, 4–6 are moderate pain, while 7–10 are in the severe pain category.

Statistical Analysis

Mann–Whitney and chi-squared tests were used for data processing relationship analysis. A P-value of less than 0.05 was considered statistically significant.

Ethical Clearance

All patients gave their informed permission in writing. This study complied with all relevant ethical regulations (including The Declaration of Helsinki) and covering patient data confidentiality. The correct ethics procedure were followed. Ethical clearance for the study (LB.02.01/X.6.5/461/2023) was granted by the research ethics committee at Hasan Sadikin General Hospital in Bandung, Indonesia.

Results

Sixty-five patients met the inclusion criteria in this study. In general, the CVST patient population in this study was dominated by women, (76.9%), indicating that women have a higher risk of developing CVST.

In Table 1, the mean age of CVST patients was 47 years, and transversus sinus was the most sinus involvement. It was found that a number of patients had a history of previous disease, with dyslipidemia being the most common.

Table 1 Clinical Characteristic of Research Subjects

Patients with multiple sinus involvement had initial, after treatment, and delta NRS higher than single sinus involvement (Table 2). Most of patient with multiple sinus had moderate level using NRS, which higher NRS compared with single sinus involvement (Table 3).

Table 2 Relationship Between NRS and Amount of Sinus Involvement

Table 3 Relationship Between Level of NRS and Amount of Sinus Involvement

Table 4 shows the relationship between elevated D-dimer levels, NRS level, and amount of sinus involvement. There was a clinical significant relationship between D-dimer level, NRS values, and amount of sinus involvement in CVST patients.

Table 4 Relationship Between D-Dimer Level, NRS, and Amount of Sinus Involvement

Figure 1 shows area under curve of D-dimer level and amount of sinus involvement. Cutoff D-dimer level is 0.0342 that has higher risk for multiple sinus involvement in CVST patients.

Figure 1 Area under the curve of D-dimer level and amount of sinus involvement.

Discussion

Characteristics of Research Subjects

This study involved 65 CVST patients, mostly women (76.9%), indicating that women have a higher risk of developing CVST. Hormonal factors, hypercoagulation condition such as antiphospholipid syndrome, genetic susceptibility, and acquired prothrombotic disorders such as pregnancy, puerperium, contraceptive pills, malignancy, infection, and trauma are the main risk factors for developing CVST.5 The mean age of the patients in this study was 47±12 years. Uluduz et al reported that CVST is more common in women than men (3:1) compared to men with an mean age of 43.2±13 years.11

A number of CVST patients involved in this study had a history of previous diseases such as autoimmune disease, carcinoma, dyslipidemia, diabetes mellitus, head injury, and a medical history of injectable birth control. The most common in this study was dyslipidemia. This is different from several studies that the characteristics of the disease history in CVST patients are not dominated by dyslipidemia. This shows that there is a correlation in several medical histories that have the potential to be risk factors for CVST.12,13

In this study it was found that CVST patients had the possibility of sinus involvement ranging from single to multiple, several sinuses may be involved, namely the transverse sinus, sigmoid sinus, sagittal sinus, and cavernous sinus. The sinus most frequently involved in the patients in this study was the left transverse sinus with some patients involving more than one sinus. In accordance with previous research, the sinuses most often affected are the transverse and sagittal sinuses, which can be involved singly or involve several sinuses simultaneously in one patient.14

Differences in NRS Values with the Number of Sinuses Involvement

Headache is the mostly common symptom of CVST suffered followed by decreased consciousness, seizures, and focal neurological deficits. Headache complaints themselves can be measured in intensity using the numeric rating scale (NRS) on a pain scale from 0 to 10 with the criteria of no pain, mild to severe.10

Patients with multiple sinus involvement in this study had a higher average initial NRS, namely 8 (severe pain) compared to those with single sinus involvement, which averaged 4 (moderate pain). This supports that patients with more than one of sinus involvement tend to have higher levels of initial headache intensity compared with patients with one of sinus involvement. In accordance with research conducted by Patil et al and Fan Y et al, headache symptoms and remaining neurological deficits were more severe in CVST patients involving multiple sinuses.10,15 The types of headaches that appear are said to be different, some are said they were similar to migraines, cluster headaches, tension type headaches, and thunderclap headaches. The location of the pain is also mentioned differently, such as the sinuses most often involved, namely the transverse sinus and superior sagittal sinus, severe headaches that are felt are often called holocranial or bifrontal.9 From previous research in France, approximately 123 CVST patients were found to have sinus headaches and most frequently involved is the transverse sinus, the headache that appears is often ipsilateral to the sinus involved. Involvement of sigmoid sinus only or with the transverse sinus, headaches often occur in the occipital area.9

Single sinus involvement in patients had a difference between initial NRS and NRS after therapy of 2 with a range of 0–5, while patients with multiple sinus involvement had a higher difference, namely 3 with a range of 0–6. So, single sinus involvement patients have significant improvement in pain compared to multiple sinus involvement using NRS after initial therapy. According to Botta et al, headache with multiple sinus involvement has a wider headache area and higher intensity because it involves a mechanism of increasing intracranial pressure, causing widespread stretching of the dura, but headache in single sinus involvement because of stretching of the dura which is innervated by branches of the trigeminal nerve area.9

Patients with multiple sinus involvement have an average NRS is higher than patients with single sinus involvement. So, it can be concluded that despite therapy, patients with multiple sinus involvement still tend to experience higher levels of pain, it means more severe than in patients with single sinus involvement. There is no any difference definitive treatment between single and multiple sinus involvement, but in multiple sinus involvement have longer duration of treatment and experience symptoms compared with single sinus. These significant results are supported by research conducted by Patil et al and Shakibajahromi et al, namely that if a patient’s CVST involves more than one sinus, the headache felt will be more extensive and severe, and the sequelae and clinical outcomes will be more severe than single sinus involvement.10,16

Thus, in the analysis of this study it was found that multiple sinus involvement was more likely to cause a more severe level of pain, both before and after therapy, but the results of changes in the NRS criteria loss a significant difference between these two groups of patients after analysis. This study result provides important insights for further understanding the influence of the number of sinuses involved on pain levels and response to therapy in CVST patients.

D-dimer Level, NRS, and Amount of Sinus Involvement

The presence of D-Dimer may be used as an indicator of endogenous fibrinolysis in CVST. D-dimers are cross-linked fibrin fragments that have a high sensitivity for investigating cerebral venous thrombosis, and elevation of D-dimer is strongly associated with the number of sinuses involved because of the amount of thrombus formation circumstances that arise. High levels of D-dimer will cause presence of larger thrombi.4

Increasing of D-dimer level in CVST patients were observed to be strongly associated with the number of sinus involvement and also with NRS. Multiple sinus involvement has a wider headache area and higher intensity because it involves a mechanism of increasing intracranial pressure, causing widespread stretching of the dura due to wider thrombus formation and extension in cerebral sinus, and it will influence NRS level.4

Based on this research, the initial headache intensity in CVST patients assessed using NRS as well as the number of sinus involvement and level of D-dimer, can be used as objective indicators by clinicians in the future to assess the prognosis of CVST patients.

Limitation of Study

This research is retrospective in nature so the data taken may be limited to the notes listed in the medical record, which may not always be complete and accurate and does not take into account the treatment of the patient, so it is possible that the research patients are not homogeneous. The pain scale assessment in this study was still high in subjectivity so it was considered to influence the assessment results.

Conclusion

Based on the results of the research above, it was concluded that D-dimer level, NRS, and amount of sinus involvement are associated with amount of sinus involvement in CVST patients. Involvement of multiple sinus will cause higher NRS with higher D-dimer level. Further research needs to be carried out prospectively with a more homogeneous sample size by carrying out subjective assessments of pain.

Funding

No funding was received for this study.

Disclosure

The authors report no conflicts of interest in this work.

References

1. Algahtani HA, Aldarmahi AA. Trombosis Sinus Vena Serebral. Neurosciences. 2014;19(1):11–16.

2. Meriggioli MN, Sanders DB. Autoimmune MG: emerging clinical and biological heterogeneity. Lancet Neurol. 2019;8(5):475–490. doi:10.1016/S1474-4422(09)70063-8

3. Caso V, Agnelli G, Paciaroni M. Handbook on Cerebral Venous Trombosis. Front Neurol Neurosci. 2018;23:1–111.

4. Amalia L, Lisda Amalia. D-dimer level associated with amount of sinus involvement using digital subtraction angiography on cerebral venous thrombosis patients. J Blood Med. 2023;14:303–308. doi:10.2147/JBM.S399661

5. Amalia L. Karakteristik klinis pasien trombosis sinus venosus serebral (CVST) di ruang rawat inap neurologi rumah sakit hasan sadikin bandung. J Neuroanestesi Indones. 2020;9(2):71–77. doi:10.24244/jni.v9i2.244

6. Saposnik, Saposnik G, Barinagarrementeria F, et al. Diagnosis and management of cerebral venous trombosis: a statement for healthcare professionals from the American heart association/American stroke association. Stroke. 2011;42(4):1158–1192. doi:10.1161/STR.0b013e31820a8364

7. Giancal A, Melina V. Epidemiology of cerebral vein and sinus trombosis. Dalam: caso V, Angelli G, Paciaroi M. Handbook on cerebral venous trombosis. Front Neurol Neurosci. 2018;36(3).

8. Stam J. Cerebral venous and sinus trombosis: incidence and causes in ischemic stroke. Adv Neurol. 2009;92:225–232.

9. Botta R, Donirpathi S, Yadav R, Kulkarni GB, Kumar MV, Nagaraja D. Headache patterns in cerebral venous sinus thrombosis. J Neurosci Rural Pract. 2017;8(Suppl 1):S72–S77. doi:10.4103/jnrp.jnrp_339_16

10. Patil VC, Choraria K, Desai N, Agrawal S. Clinical profile and outcome of cerebral venous sinus thrombosis at tertiary care center. J Neurosci Rural Pract. 2014;5(3):218–224. doi:10.4103/0976-3147.133559

11. Uluduz D, Sahin S, Duman T, et al. Cerebral venous sinus thrombosis in women: subgroup analysis of the VENOST study. Stroke Res Treat. 2020;2020:8610903. doi:10.1155/2020/8610903

12. Jaiswal V, Nepal G, Dijamco P, et al. Cerebral venous sinus thrombosis following COVID-19 vaccination: a systematic review. J Prim Care Community Health. 2022;13:21501319221074450. PMID: 35142234; PMCID: PMC8841914. doi:10.1177/21501319221074450

13. Jiao L, Huang X, Fan C, et al. Clinical characteristics and management of cerebral venous sinus thrombosis in patients with essential thrombocythemia. Neuropsychiatr Dis Treat. 2021;17:1195–1206. PMID: 33911867; PMCID: PMC8075307. doi:10.2147/NDT.S294712

14. Luo Y, Tian X, Wang X. Diagnosis and treatment of cerebral venous thrombosis: a review. Front Aging Neurosci. 2018;10:2. PMID: 29441008; PMCID: PMC5797620. doi:10.3389/fnagi.2018.00002

15. Fan Y, Yu J, Chen H Chinese Stroke Association Stroke Council CVST Guideline Writing Committee, et al. Chinese stroke association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of cerebral venous sinus thrombosis. Stroke and Vascular Neurol. 2020;5. doi:10.1136/svn-2020-000358

16. Shakibajahromi B, Borhani-Haghighi A, Vardanjani HM, et al. Isolated headache and its association with characteristics and outcome of cerebral venous sinus thrombosis. Cephalalgia Rep. 2019;3. doi:10.1177/2515816320919961

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.